KAT2B antibody (C-Term)

Catalog No. ABIN6952405

This anti-KAT2B antibody is a Rabbit Polyclonal antibody detecting KAT2B in WB, ChIP and ChIP-seq. Suitable for Human.

Quick Overview for KAT2B antibody (C-Term) (ABIN6952405)

Target: KAT2B (K(lysine) Acetyltransferase 2B (KAT2B))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This KAT2B antibody is un-conjugated

Application: Western Blotting (WB), Chromatin Immunoprecipitation (ChIP), ChIP DNA-Sequencing (ChIP-seq)

Product Details anti-KAT2B Antibody

Binding Specificity: C-Term

Specificity: Polyclonal antibody raised in rabbit against human KAT2B (Lysine Acetyltransferase 2B), using a synthetic peptide containing a sequence from the C-terminal part of the protein.

Purification: Affinity purified

Immunogen: synthetic peptide

Application Details

Application Notes: ChIP/ChIP-seq 2 μg:ChIP
WB 1:1,000

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 μg/μL

Buffer: Tris-citrate/phosphate buffer, 0.05 % azide

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Target Details for KAT2B

Target: KAT2B (K(lysine) Acetyltransferase 2B (KAT2B))

Alternative Name: KAT2B

Background: KAT2B (UniProtKB/Swiss-Prot entry Q92831) functions as a histone acetyltransferase, thereby promoting transcriptional activation. KAT2B binds with CBP and p300 where it competes with the adenoviral oncoprotein E1A for binding sites and as such counteracts the mitogenic activity of E1A. KAT2B also acts as a circadian transcriptional coactivator which enhances the activity of the circadian transcriptional activators NPAS2-ARNTL/BMAL1 and CLOCK-ARNTL/BMAL1 heterodimers.

UniProt: Q92831

Pathways: p53 Signaling, Regulation of Carbohydrate Metabolic Process